OUTCOMES OF HEPATITIS B AND TUBERCULOSIS SCREENING IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) FOR RHEUMATIC DISEASE AT A MELBOURNE PUBLIC HOSPITAL

被引：0
|
作者：
Pourhadi, H. [1 ]
Johnson, A. [1 ]
Foote, A. [1 ]
机构：
[1] Northern Hlth, Rheumatol, Epping, NSW, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Vaccination/Immunization; bDMARD; Quality of care;
D O I：
10.1136/annrheumdis-2023-eular.5494
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1618
引用
收藏
页码：2043 / 2044
页数：2
相关论文
共 50 条
  • [21] USE OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN A COHORT OF PATIENTS WITH IGG4-RELATED DISEASE
    Fernandez-Codina, A.
    Pinal-Fernandez, I.
    Orozco-Galvez, O.
    Solans-Laque, R.
    Bujan-Rivas, S.
    Fonollosa-Pla, V.
    Vilardell-Tarres, M.
    Martinez-Valle, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 398 - 398
  • [22] The role of registries in the treatment of rheumatoid arthritis with biologic disease-modifying anti-rheumatic drugs
    Pombo-Suarez, Manuel
    Gomez-Reino, Juan
    PHARMACOLOGICAL RESEARCH, 2019, 148
  • [23] Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia
    Donges, E.
    Staatz, C. E.
    Benham, H.
    Kubler, P.
    Hollingworth, S. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 907 - 912
  • [24] DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    STECHER, VJ
    CARLSON, JA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1983, 18 : 171 - 179
  • [25] SAFETY AND EFFECTIVENESS OF DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) IN OLDER ADULTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT STUDY
    Akter, Ripa
    Maksymowych, Walter P.
    Martin, Liam
    Hogan, David
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1134 - 1135
  • [26] RHEUMATOID-ARTHRITIS - DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    KIRWAN, JR
    CURREY, HLF
    CLINICS IN RHEUMATIC DISEASES, 1983, 9 (03): : 581 - 599
  • [27] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    Kristin M. D’Silva
    Zachary S. Wallace
    Current Rheumatology Reports, 2021, 23
  • [28] COVID-19 and Disease-Modifying Anti-rheumatic Drugs
    D'Silva, Kristin M.
    Wallace, Zachary S.
    CURRENT RHEUMATOLOGY REPORTS, 2021, 23 (05)
  • [29] Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs
    Behnaz Yousefghahari
    Sanaz Navari
    Mahmoud Sadeghi
    Shima Soleimaniamiri
    Mohammadjafar Soleimaniamiri
    Behzad Heidari
    Mansour Babaei
    Kian Ghodrati
    Ardeshir Guran
    Hemmat Gholinia
    Clinical Rheumatology, 2021, 40 : 4309 - 4315
  • [30] Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs
    Yousefghahari, Behnaz
    Navari, Sanaz
    Sadeghi, Mahmoud
    Soleimaniamiri, Shima
    Soleimaniamiri, Mohammadjafar
    Heidari, Behzad
    Babaei, Mansour
    Ghodrati, Kian
    Guran, Ardeshir
    Gholinia, Hemmat
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4309 - 4315
12345